Advancing Treatments for ADNP Syndrome Through the Oxford-Harrington Rare Disease Centre @UniversityHospitals
Advancing Treatments for ADNP Syndrome Through the Oxford-Harrington Rare Disease Centre  @UniversityHospitals
Uploaded September 2026 | Updated September 2026, 1 week ago
Meet Genie and her children, Rowland and Charlotte. Rowland lives with ADNP syndrome, a rare genetic disorder associated with autism and developmental challenges. Their family’s story is connected to the work of Oxford-Harrington Rare Disease Scholar Dr. Joseph Buxbaum, who is advancing research toward potential treatments for ADNP syndrome.

The Oxford-Harrington Rare Disease Centre helps accelerate the development of new medicines for rare diseases by supporting leading researchers, fostering collaboration between academia and industry, and providing resources to move promising discoveries closer to patients. Established through a partnership between the University of Oxford and Harrington Discovery Institute at University Hospitals, the Oxford-Harrington Rare Disease Centre combines world-class scientific expertise with drug development support to help translate promising research into potential therapies for patients in need.
Advancing Treatments for ADNP Syndrome Through the Oxford-Harrington Rare Disease CentreHeidi Goodwin, CNP - Surgical OncologyExecutive Health Program at University HospitalsRaisa Tikhtman, MD - Head & Neck SurgeryUnlocking Exercises Secret: Irisins Potential in Alzheimers TreatmentMaria Tomaro, CNP - Hematology & OncologyLake County Heart & Vascular ExpertsMujjahid Abbas, MD - Bariatric SurgeryUniversity Hospitals Global Health Grand Rounds with Beena Kamath-Rayne, MD, MPH, FAAP.Katherine Daunov, CNP - Hematology & OncologyAmelia Baffa, CNP - Pediatric Hematology & OncologyResham Ramkissoon, MD - Hepatology
University Hospitals |

Advancing Treatments for ADNP Syndrome Through the Oxford-Harrington Rare Disease Centre

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER